SAREPTA THERAPEUTICS, INC. Assets, Fair Value Disclosure
SAREPTA THERAPEUTICS, INC. (SRPT) had Assets, Fair Value Disclosure of $577.04 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-05
- 2026-06-30: Assets, Fair Value Disclosure $577.04M.
- 2026-03-31: Assets, Fair Value Disclosure $496.29M.
- 2025-12-31: Assets, Fair Value Disclosure $714.65M.
- 2025-09-30: Assets, Fair Value Disclosure $404.56M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $577.04M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $496.29M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $714.65M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $404.56M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $673.41M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $612.27M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $844.19M 10-K · filed 2026-03-02 |
| 2024-09-30 | $1.26B 10-Q · filed 2024-11-06 |
| 2024-06-30 | $1.22B 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.28B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $1.37B 10-K · filed 2025-02-28 |
| 2023-09-30 | $1.42B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $1.49B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.57B 10-Q · filed 2023-05-02 |
| 2022-12-31 | $1.69B 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.69B 10-Q · filed 2022-11-02 |
| 2022-06-30 | $1.60B 10-Q · filed 2022-08-02 |
| 2022-03-31 | $1.60B 10-Q · filed 2022-05-04 |
| 2021-12-31 | $1.60B 10-K · filed 2023-02-28 |
| 2021-09-30 | $1.32B 10-Q · filed 2021-11-03 |
| 2021-06-30 | $1.45B 10-Q · filed 2021-08-04 |
| 2021-03-31 | $1.45B 10-Q · filed 2021-05-05 |
| 2020-12-31 | $1.71B 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.55B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.77B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.80B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $1.05B 10-K · filed 2021-03-01 |
| 2019-09-30 | $898.17M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $998.79M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.10B 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.01B 10-K · filed 2020-02-26 |
| 2018-09-30 | $799.41M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $765.93M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $911.89M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $909.06M 10-K · filed 2019-02-28 |
| 2017-09-30 | $558.70M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $197.89M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $197.56M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $207.91M 10-K · filed 2018-03-01 |
| 2016-09-30 | $47.95M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $47.84M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $102.68M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $161.38M 10-K · filed 2017-02-28 |
| 2015-09-30 | $66.67M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $95.77M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $145.70M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $185.18M 10-K · filed 2016-02-25 |
| 2014-09-30 | $188.94M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $188.96M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $192.15M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $192.90M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |